Vaccines (Jul 2023)

Testing Efficacy of a Conserved Polypeptide from the Bm86 Protein against <i>Rhipicephalus microplus</i> in the Mexican Tropics

  • Raymundo Coate,
  • Miguel Ángel Alonso-Díaz,
  • Moisés Martínez-Velázquez,
  • Edgar Castro-Saines,
  • Rubén Hernández-Ortiz,
  • Rodolfo Lagunes-Quintanilla

DOI
https://doi.org/10.3390/vaccines11071267
Journal volume & issue
Vol. 11, no. 7
p. 1267

Abstract

Read online

Rhipicephalus microplus economically impacts cattle production in tropical and subtropical countries. Application of acaricides constitutes the major control method; however, inadequate use has increased resistant tick populations, resulting in environmental and cattle product contamination. Anti-tick vaccines based on the Bm86 antigen are an environmentally friendly, safe, and economically sustainable alternative for controlling R. microplus infestations. Nevertheless, variable efficacy has been experienced against different geographic tick strains. Herein, we evaluated the efficacy of a conserved polypeptide Bm86 derived from a Mexican R. microplus strain previously characterized. Twelve cows were assigned to three experimental groups and immunized with three doses of the polypeptide Bm86 (pBm86), adjuvant/saline alone, and Bm86 antigen (control +), respectively. Specific IgG antibody levels were measured by ELISA and confirmed by Western blot. In addition, the reproductive performance of naturally infested R. microplus was also determined. The more affected parameter was the adult female tick number, with a reduction of 44% by the pBm86 compared to the controls (p R. microplus. The negative correlation between antibody levels and the reduction of naturally tick-infested cattle suggested that the effect of the polypeptide Bm86 was attributed to the antibody response in immunized cattle. In conclusion, the polypeptide Bm86 showed a specific immune response in cattle and conferred protection against R. microplus in a Mexican tropical region. These findings support further experiments with this antigen to demonstrate its effectiveness as a regional vaccine.

Keywords